Progession of AML treatment over the past decades
Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.
Ibrutinib in combination with rituximab – the future of treating FL
Nathan Hale Fowler
Lymphoid Highlights from BSH 2017